Updated IDSA Guidelines out now! IDSA has released updated evidence-based guidelines on COVID-19, influenza, and RSV vaccinations in the immunocompromised population.
Access the guidelines: https://t.co/YrXkPITLX5
Our press release: https://t.co/bQC3ANb66o
Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia
✅ Just Accepted
✍️ @raneempallotta
🔗 https://t.co/jNdwWlkGXL